No Data
Ark Health (06086.HK) achieved revenue of over 2.7 billion yuan for the fiscal year 2024, with adjusted net profit significantly increasing by 139%.
On March 21, the company announced its annual performance, reporting revenue of 2.707 billion yuan for the year ending December 31, 2024, an increase of 11.22% year-on-year; the adjusted net profit for 2024 is expected to grow significantly by 139% compared to 2023, benefiting from continuous technological enhancements and improved Operation efficiency. During the reporting period, the platform experienced strong growth, with increased user engagement. As of December 31, 2024, the platform's registered users rose to 49.2 million. For the twelve months ending December 31, 2024, the average monthly active users reached.
Express News | Fangzhou Inc - Loss and Total Comprehensive Income for Year RMB854.9 Mln
Express News | Fangzhou Inc - FY Revenue RMB2.71 Bln
FANGZHOU JIANKE: ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED DECEMBER 31, 2024
Hong Kong stocks movement | Ark Health (06086) rose over 17% during the session. DeepSeek accelerates the implementation of AI Medical, and the company will focus on developing multiple "Asia Vets smart assistant" scenarios this year.
Arc Health (06086) rose over 17% during the session, and as of this writing, is up 13.36%, priced at 5.77 Hong Kong dollars, with a transaction volume of 0.138 billion Hong Kong dollars.
Hong Kong stocks movement | Ark Health (06086) rose over 6% against the trend as the company recently entered the Hong Kong Stock Connect list and accessed DS to provide personalized medical services.
Ark Health (06086) rose over 6% against the market trend. As of the time of writing, it has increased by 2.71%, priced at 4.92 Hong Kong dollars, with a transaction volume of 25.8659 million Hong Kong dollars.
